Search

everythinglearnresearchcommunity

for

Search:↓

DPCP is more effective than tretinoin gel for treating severe alopecia.

Pembrolizumab can cause serious liver issues, requiring close monitoring and early treatment.

Antiretrovirals can affect finasteride's effectiveness, so dose adjustments may be needed for men on HIV treatment.

Polydeoxyribonucleotide (PDRN) may help lighten skin and treat hyperpigmentation.

Pranlukast and mirabegron may work as new diabetes drugs.

Pazopanib treatment caused rapid hair color loss, possibly indicating its effectiveness.

The chitosan/PDRN polyplex improved wound healing in diabetic rats.

DOPE:DOPC liposomes can improve targeted cancer drug delivery, reducing side effects and increasing effectiveness.

Diphenylcyclopropenone (DPCP) is more effective than anthralin for treating resistant alopecia areata.

New treatments for enlarged prostate are being developed, some of which may be more effective than current medications.

Tadalafil may reduce the risk of major heart events and blood clots in men with urinary symptoms.

Medications for PCOS don't seem to raise heart disease risk.

Combining negative pressure therapy with platelet-rich plasma speeds up healing and lowers death risk in diabetic foot ulcers.

Dupilumab may help children with alopecia areata and atopic dermatitis regrow hair.

Doxazosin and finasteride negatively affect sexual function in men with BPH.

DA-9401 can protect against finasteride-induced reproductive damage in rats.

The thulium laser and PDRN injections effectively improved hair thickness in patients with pattern hair loss.

Dutasteride may help shrink prostate cancer tumors.

New steroids were patented as effective for treating acne, hair loss, and other conditions related to hormones.

Linagliptin may cause hair loss and skin blisters.

Using CDK inhibitors on rats showed a reduction in chemotherapy-caused hair loss, but later experiments could not repeat these results.

Upadacitinib may effectively treat resistant lichen planopilaris.

The research gives new understanding on how human steroid 5α-reductases work and how drugs like finasteride inhibit them, which could help in creating new drugs.

New pyridine compounds effectively inhibit GSK3, a diabetes treatment target.

Finasteride and dutasteride reduce prostate cancer risk, but finasteride may increase higher-grade cancer risk.

Antisense oligonucleotides show promise for treating Myotonic Dystrophy type I.

Proteasome inhibitors are promising treatments for various cancers, autoimmune diseases, and other conditions.

The conclusion is that future trials should report specific details about the PRP composition to better understand its effects on urologic conditions.